Abstract
Gaucher disease (GD) is an autosomal recessive, lysosomal disorder caused by mutations in the gene for the β-glucocerebrosidase (GBA) enzyme. Presence of the non-functional GBAP pseudogene, which shares high sequence similarity with the functional GBA gene, has made it difficult to carry out molecular analyses of GD, especially recombinant mutations. Using a long-range PCR approach that has been skillfully devised for the easy detection of GBA recombinant mutations, we identified four recombinant mutations including two gene conversion alleles, Rec 1a and Rec 8a, one reciprocal gene fusion allele, Rec 1b, and one reciprocal gene duplication allele, Rec 7b, in Korean patients with GD. Rec 8a, in which the GBAP pseudogene sequence from intron 5 to exon 11 is substituted for the GBA gene is a novel recombinant mutation. All mutations were confirmed by full sequencing of PCR amplicons and/or Southern blot analysis. These results indicate that the usage of long-range PCR may allow the rapid and accurate detection of GBA recombinant mutations and contribute to the improvement of genotyping efficiency in GD patients.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Beutler, E. Gaucher's disease. N. Engl. J. Med. 325, 1354–1360 (1991).
Horowitz, M., Wilder, S., Horowitz, Z., Reiner, O., Gelbart, T. & Beutler, E. The human glucocerebrosidase gene and pseudogene: structure and evolution. Genomics. 4, 87–96 (1989).
Long, G. L., Winfield, S., Adolph, K. W., Ginns, E. I. & Bornstein, P. Structure and organization of the human metaxin gene (MTX) and pseudogene. Genomics. 33, 177–184 (1996).
Tayebi, N., Stubblefield, B. K., Park, J. K., Orvisky, E., Walker, J. M., LaMarca, M. E. et al. Reciprocal and nonreciprocal recombination at the glucocerebrosidase gene region: implications for complexity in Gaucher disease. Am. J. Hum. Genet. 72, 519–534 (2003).
Hruska, K. S., LaMarca, M. E., Scott, C. R. & Sidransky, E. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum. Mutat. 29, 567–583 (2008).
Jeong, S. Y., Park, S. J. & Kim, H. J. Clinical and genetic characteristics of Korean patients with Gaucher disease. Blood Cells Mol. Dis. 46, 11–14 (2011).
Miocic, S., Filocamo, M., Dominissini, S., Montalvo, A. L., Vlahovicek, K., Deganuto, M. et al. Identification and functional characterization of five novel mutant alleles in 58 Italian patients with Gaucher disease type 1. Hum. Mutat. 25, 100 (2005).
Eyal, N., Wilder, S. & Horowitz, M. Prevalent and rare mutations among Gaucher patients. Gene. 96, 277–283 (1990).
Tayebi, N., Cushner, S. & Sidransky, E. Differentiation of the glucocerebrosidase gene from pseudogene by long-template PCR: implications for Gaucher disease. Am. J. Hum. Genet. 59, 740–741 (1996).
Reissner, K., Tayebi, N., Stubblefield, B. K., Koprivica, V., Blitzer, M., Holleran, W. et al. Type 2 Gaucher disease with hydrops fetalis in an Ashkenazi Jewish family resulting from a novel recombinant allele and a rare splice junction mutation in the glucocerebrosidase locus. Mol. Genet. Metab. 63, 281–288 (1998).
Zimran, A., Sorge, J., Gross, E., Kubitz, M., West, C. & Beutler, E. A glucocerebrosidase fusion gene in Gaucher disease. Implications for the molecular anatomy, pathogenesis, and diagnosis of this disorder. J. Clin. Invest. 85, 219–222 (1990).
Horowitz, M., Tzuri, G., Eyal, N., Berebi, A., Kolodny, E. H., Brady, R. O. et al. Prevalence of nine mutations among Jewish and non-Jewish Gaucher disease patients. Am. J. Hum. Genet. 53, 921–930 (1993).
Koprivica, V., Stone, D. L., Park, J. K., Callahan, M., Frisch, A., Cohen, I. J. et al. Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease. Am. J. Hum. Genet. 66, 1777–1786 (2000).
Cormand, B., Harboe, T. L., Gort, L., Campoy, C., Blanco, M., Chamoles, N. et al. Mutation analysis of Gaucher disease patients from Argentina: high prevalence of the RecNciI mutation. Am. J. Med. Genet. 80, 343–351 (1998).
Wan, L., Hsu, C. M., Tsai, C. H., Lee, C. C., Hwu, W. L. & Tsai, F. J. Mutation analysis of Gaucher disease patients in Taiwan: high prevalence of the RecNciI and L444P mutations. Blood Cells Mol. Dis. 36, 422–425 (2006).
Tajima, A., Yokoi, T., Ariga, M., Ito, T., Kaneshiro, E., Eto, Y. et al. Clinical and genetic study of Japanese patients with type 3 Gaucher disease. Mol. Genet. Metab. 97, 272–277 (2009).
Acknowledgements
This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2007-0054214, 2009-0075599 and KRF-2008-314-C00258).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on Journal of Human Genetics website
Rights and permissions
About this article
Cite this article
Jeong, SY., Kim, SJ., Yang, JA. et al. Identification of a novel recombinant mutation in Korean patients with Gaucher disease using a long-range PCR approach. J Hum Genet 56, 469–471 (2011). https://doi.org/10.1038/jhg.2011.37
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/jhg.2011.37
Keywords
This article is cited by
-
Comprehensive short and long read sequencing analysis for the Gaucher and Parkinson’s disease-associated GBA gene
Communications Biology (2022)
-
Gaucher disease: clinical phenotypes and refining GBA mutational spectrum in Thai patients
Orphanet Journal of Rare Diseases (2021)
-
False negatives in GBA1 sequencing due to polymerase dependent allelic imbalance
Scientific Reports (2021)
-
The GBA p.G85E mutation in Korean patients with non-neuronopathic Gaucher disease: founder and neuroprotective effects
Orphanet Journal of Rare Diseases (2020)
